Wooliscroft, Lindsey
Silbermann, Elizabeth
Cameron, Michelle
Bourdette, Dennis
Article History
First Online: 28 June 2019
Compliance with Ethical Standards
:
: Lindsey Wooliscroft and Elizabeth Silbermann each declare no potential conflicts of interest. Michelle Cameron reports consulting fees from Adamas Pharmaceuticals and Greenwich Biosciences outside the submitted work. Dennis Bourdette reports consultancy for reviewing patient medical records and providing opinion on treatments for Magellan Health Care and Best Doctors Inc. He also served as an expert witness on MS for the US Department of Justice, reports a bench research grant and collaborative center award from the National MS Society, and reports a founder’s stock valued at $1000 from Llama Therapeutics.
: This article does not contain any studies with human or animal subjects performed by any of the authors.